MaxCyte, Inc.

MXCT ·Healthcare, Diagnostics & Research, United States
Balance Sheet › Asset & Liabilities Breakdown

Asset & Liabilities Breakdown

Asset Breakdown FY2024

Total Assets: $239.5M

Liabilities Breakdown FY2024

Total Liabilities: $33.2M